BioSpace News Archive

Digital Healthcare Firm Offers Doctors Free Webinar on Using Facebook, Smartphones for Telehealth During Coronavirus Crisis

Following Federal Policy Changes, Healthcare Specialist Vanguard Communications Presents “Patient in a Pocket” Webinar About Conducting Patient Appointments Virtually Via Common Apps

March 23, 2020
·
3 min read
Genetown

Harvard Bioscience Introduces Next Generation Inhalation System to Aid in the Fight Against COVID-19Company will continue to manufacture and ship innovative products for global development and research throughout crisis

Harvard Bioscience, Inc. (Nasdaq: HBIO) has launched an innovative technology – known as Accumulated Inhaled Aerosol (AIA) – for academic researchers, contract research organizations (CROs) and pharmaceutical companies involved in pre-clinical inhalation and exposure studies. With our new Buxco® AIA system, researchers are presented with real-time aerosol amounts inhaled and deposited in subjects’ lungs, a breakthrough improvement over the

March 23, 2020
·
4 min read
Business

BioNTech to report full year financial results for 2019 and provide corporate update on the fourth quarter on March 31, 2020

BioNTech SE will announce its financial results for the full year 2019 on Tuesday, March 31st, 2020.

March 23, 2020
·
2 min read
Business

Myriad Announces Board of Directors Leadership Transition

Myriad Genetics, Inc., a global leader in molecular diagnostics and precision medicine, announced that S. Louise Phanstiel has been appointed as chair of the Board of Directors. John T. Henderson, M.D., will remain on the Board of Directors..

March 23, 2020
·
6 min read
Resverlogix Invites Collaborations for use of Apabetalone in Trials and Studies to Combat the Spread of COVID-19 Based on New Research

Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19

March 23, 2020
·
4 min read
Akumin designates imaging centers for COVID-19 response

Akumin Inc. announced it will be dedicating 10 of its freestanding, outpatient diagnostic imaging centers across its regions to focus specifically on patients who have been diagnosed with an active case of COVID-19, the disease caused by the novel coronavirus, or who have similar symptoms.

March 23, 2020
·
5 min read
Business

AlloVir Expands Its Research Collaboration with Baylor College of Medicine to Discover and Develop Allogeneic, Off-the-Shelf, Virus-Specific T-Cell Therapies for COVID-19

AlloVir’s proprietary technology is designed to develop virus specific T-cell therapies with potential to treat and prevent several devastating viral diseases with each single cell therapy product

March 23, 2020
·
7 min read
Drug Development

Biohaven to Advance Vazegepant into Phase 3 for the Acute Treatment of Migraine Following Successful End of Phase 2 Meeting with FDA

- In previously reported positive topline results from pivotal Phase 2/3 clinical trial in December 2019, vazegepant achieved statistical superiority to placebo on the co-primary regulatory endpoints of pain freedom and freedom from most bothersome symptom at 2 hours - Vazegepant is a third generation, high affinity, selective and structurally unique, small molecule CGRP receptor antagonist from Biohaven’s NOJECTION™ Migraine Platform and the only intranasal CGRP receptor antagonist in

March 23, 2020
·
6 min read
Government of Quebec providing $7 million towards Medicago’s COVID-19 vaccine development

Quebec City biopharmaceutical company moving towards testing stages of COVID-19 vaccine candidate

March 23, 2020
·
2 min read
Biotech Bay

Eiger BioPharmaceuticals Completes Submission of New Drug Application to FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies

Eiger BioPharmaceuticals, Inc. today announced that it has completed submission to the U.S. Food and Drug Administration of a new drug application

March 23, 2020
·
7 min read